Cita APA

Edelmann, J., Tausch, E., Landau, D. A., Robrecht, S., Bahlo, J., Fischer, K., . . . Stilgenbauer, S. (2016). Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: Results from the CLL8 trial. Leukemia.

Chicago Style Citation

Edelmann, Jennifer, et al. "Frequent Evolution of Copy Number Alterations in CLL Following First-line Treatment With FC(R) Is Enriched With TP53 Alterations: Results From the CLL8 Trial." Leukemia 2016.

Cita MLA

Edelmann, Jennifer, et al. "Frequent Evolution of Copy Number Alterations in CLL Following First-line Treatment With FC(R) Is Enriched With TP53 Alterations: Results From the CLL8 Trial." Leukemia 2016.